Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa

Affiliations

¹ Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. Electronic address: ivor.langley@lstmed.ac.uk.
² Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei City, Taiwan.
³ Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.

Free article

Comment

Ivor Langley et al. Lancet Glob Health. 2015 Feb.

Free article

. 2015 Feb;3(2):e83-4.

doi: 10.1016/S2214-109X(14)70370-5.

¹ Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK. Electronic address: ivor.langley@lstmed.ac.uk.
² Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei City, Taiwan.
³ Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.

No abstract available

Comment on

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa.
Dheda K, Theron G, Welte A. Dheda K, et al. Lancet Glob Health. 2014 Oct;2(10):e554-6. doi: 10.1016/S2214-109X(14)70305-5. Lancet Glob Health. 2014. PMID: 25304623 No abstract available.
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
Langley I, Lin HH, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. Langley I, et al. Lancet Glob Health. 2014 Oct;2(10):e581-91. doi: 10.1016/S2214-109X(14)70291-8. Lancet Glob Health. 2014. PMID: 25304634